ALXO
Alx Oncology Holdings Inc

1,263
Mkt Cap
$307M
Volume
208,021.00
52W High
$2.42
52W Low
$0.404
PE Ratio
-1.15
ALXO Fundamentals
Price
$2.26
Prev Close
$2.34
Open
$2.26
50D MA
$1.44
Beta
1.45
Avg. Volume
348,234.90
EPS (Annual)
-$2.58
P/B
2.80
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
Here is how ALX Oncology Holdings Inc. (ALXO) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Insider Buying: ALX Oncology (NASDAQ:ALXO) Director Purchases $4,999,999.41 in Stock
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) Director Corey Goodman bought 3,184,713 shares of ALX Oncology stock in a transaction that occurred on Monday, February 2nd. The stock was...
MarketBeat·5d ago
News Placeholder
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the firm, Marketbeat reports...
MarketBeat·14d ago
News Placeholder
ALX Oncology Spotlights Evorpacept HER2 Strategy and EGFR ADC ALX2004 Progress at JPM Conference
ALX Oncology (NASDAQ:ALXO) outlined progress across its two clinical-stage programs CD47 blocker evorpacept and EGFR-targeted antibody-drug conjugate (ADC) ALX2004 during a presentation at the J.P...
MarketBeat·26d ago
News Placeholder
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat...
MarketBeat·1mo ago
News Placeholder
Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,047,613 shares...
MarketBeat·1mo ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of ALX Oncology from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·2mo ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen downgraded shares of ALX Oncology from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·2mo ago
News Placeholder
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com...
MarketBeat·2mo ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded ALX Oncology from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest ALXO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.